We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
(Approval lapsed) Epirubicin Accord epirubicin hydrochloride 200mg/100mL Solution for Injection or Infusion (Austria)
Section 19A approved medicine
(Approval lapsed) Epirubicin Accord epirubicin hydrochloride 200mg/100mL Solution for Injection or Infusion (Austria)
Section 19A approval holder
Accord Healthcare Pty Ltd ABN 49 110 502 513
Phone
1800 222 673
Approved until
Status
Expired
Medicines in short supply/unavailable
EPIRUBICIN ACCORD epirubicin hydrochloride 200mg/100mL concentrated injection vial - ARTG 227997
Indication(s)
Epirubicin is used in the treatment of a range of neoplastic conditions including:
- Carcinoma of the breast
- Gastric cancer Intravesical administration
- Treatment of papillary transitional cell carcinoma of the bladder
- Treatment of carcinoma-in-situ of the bladder
- Prophylaxis of recurrences after transurethral resection of superficial tumours